We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current DBV market cap is 56.49M. The company's latest EPS is USD and P/E is N/A.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 14.71M | 23.34M | 12.8M | 5.72M | 15.73M |
Operating Income | -170.35M | -144.81M | -92.47M | -85.78M | -76.3M |
Net Income | -172.47M | -159.67M | -98.05M | -96.01M | -72.71M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 271.27M | 272.02M | 146.32M | 246.49M | 183M |
Total Liabilities | 78.54M | 66.63M | 47.29M | 52M | 42.66M |
Total Equity | 192.73M | 205.39M | 99.03M | 194.5M | 140.33M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -143.89M | -160.89M | -104.06M | -51.4M | -77.64M |
Investing | -5.66M | -2.87M | -433k | -100k | -808k |
Financing | 203.12M | 144.84M | -3.91M | 189.85M | 4.76M |
Market Cap | 56.49M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 94.15M |
Average Volume (1 week) | 206.98k |
Average Volume (1 Month) | 646.23k |
52 Week Change | -65.91% |
52 Week High | 2.072 |
52 Week Low | 0.598 |
Spread (Intraday) | 0.02 (2.76%) |
Company Name | DBV Technologies |
Address |
177-181 avenue pierre brossolette montrouge, hauts-de-seine 92120 |
Website | https://www.dbv-technologies.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions